These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38404163)

  • 41. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
    Hawkes JE; Visvanathan S; Krueger JG
    Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regional differences in the prevalence of generalized pustular psoriasis in Japan.
    Fujita H; Iwasaki R; Tsuboi S; Murashiuma Y; Akiyama M
    J Dermatol; 2024 Mar; 51(3):380-390. PubMed ID: 38292005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
    Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
    J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and genetic differences between pustular psoriasis subtypes.
    Twelves S; Mostafa A; Dand N; Burri E; Farkas K; Wilson R; Cooper HL; Irvine AD; Oon HH; Kingo K; Köks S; Mrowietz U; Puig L; Reynolds N; Tan ES; Tanew A; Torz K; Trattner H; Valentine M; Wahie S; Warren RB; Wright A; Bata-Csörgő Z; Szell M; Griffiths CEM; Burden AD; Choon SE; Smith CH; Barker JN; Navarini AA; Capon F
    J Allergy Clin Immunol; 2019 Mar; 143(3):1021-1026. PubMed ID: 30036598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identifying patients with deteriorating generalized pustular psoriasis: Development of a prediction model.
    Ohn J; Choi YG; Yun J; Jo SJ
    J Dermatol; 2022 Jul; 49(7):675-681. PubMed ID: 35491617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generalized pustular psoriasis in Brazil: A public claims database study.
    Duarte GV; Esteves de Carvalho AV; Romiti R; Gaspar A; Gomes de Melo T; Soares CP; Aguirre AR
    JAAD Int; 2022 Mar; 6():61-67. PubMed ID: 35059660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
    Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
    Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring the Clinical Assessment, Guidelines, and Options for the Treatment of Generalized Pustular Psoriasis [Podcast].
    Song EJ; Liu C
    Clin Cosmet Investig Dermatol; 2023; 16():2911-2917. PubMed ID: 37915421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with generalized pustular psoriasis progression among patients with psoriasis vulgaris in Japan: Results from a claims database study.
    Hayama K; Iwasaki R; Tian Y; Fujita H
    J Dermatol; 2023 Dec; 50(12):1531-1538. PubMed ID: 37721393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
    Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
    Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and incidence of generalized pustular psoriasis in Sweden: a population-based register study.
    Löfvendahl S; Norlin JM; Schmitt-Egenolf M
    Br J Dermatol; 2022 Jun; 186(6):970-976. PubMed ID: 34978071
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.
    Choon SE; Lebwohl MG; Marrakchi S; Burden AD; Tsai TF; Morita A; Navarini AA; Zheng M; Xu J; Turki H; Rajeswari S; Deng H; Tetzlaff K; Thoma C; Bachelez H
    BMJ Open; 2021 Mar; 11(3):e043666. PubMed ID: 33785490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiologic study in a real-world analysis of patients with treatment for psoriasis in the French national health insurance database.
    Grodner C; Sbidian E; Weill A; Mezzarobba M
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):411-416. PubMed ID: 32364321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
    Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
    Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France.
    Penso L; Dray-Spira R; Weill A; Zureik M; Sbidian E
    Br J Dermatol; 2022 Jan; 186(1):59-68. PubMed ID: 34310699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
    Bernardo D; Thaçi D; Torres T
    Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of Psoriasis.
    Gregoire ARF; DeRuyter BK; Stratman EJ
    JAMA Dermatol; 2021 Feb; 157(2):198-201. PubMed ID: 33206132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study).
    Nasser M; Larrieu S; Boussel L; Si-Mohamed S; Bazin F; Marque S; Massol J; Thivolet-Bejui F; Chalabreysse L; Maucort-Boulch D; Hachulla E; Jouneau S; Le Lay K; Cottin V
    Respir Res; 2021 May; 22(1):162. PubMed ID: 34030695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in bacterial sepsis incidence and mortality in France between 2015 and 2019 based on National Health Data System (Système National des données de Santé (SNDS)): a retrospective observational study.
    Pandolfi F; Guillemot D; Watier L; Brun-Buisson C
    BMJ Open; 2022 May; 12(5):e058205. PubMed ID: 35613798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.